Live Breaking News & Updates on Xi An Jiaotong University Health Science Center

Stay updated with breaking news from Xi an jiaotong university health science center. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

New Drug Successfully Treats Fatty Liver Disease in Primate Model

Millions of people are affected by nonalcoholic steatohepatitis (NASH), which is a serious liver disease. A newly discovered amino acid compound has been found to successfully treat nonalcoholic fatty liver disease in non-human primates, representing a significant step towards the development of th ....

United States , Yang Zhao , Zuowen Zheng , Jinpeng Zhao , Eugene Chen , Shuangshuang Chen , Wenbin Cao , Chengshuang Chu , Bo Wen , Linying Jia , Xiaojing Gao , Alexandrac Finney , Y Eugene Chen , Zhipeng Liu , Xuelian Xiong , Jifeng Zhang , Huiqing Wang , Mingming Zhao , Ying Zhao , Chao Xue , University Of Michigan , National Key Research , Laboratory Animals , Development Program Of China , Natural Science Foundation Of Shaanxi Province , National Natural Science Foundation Of China ,

Potential drug treats fatty liver disease in animal models, brings hope for first human treatment: Nonalcoholic steatohepatitis, or NASH, is a severe liver disease and impacts millions of people

Potential drug treats fatty liver disease in animal models, brings hope for first human treatment: Nonalcoholic steatohepatitis, or NASH, is a severe liver disease and impacts millions of people
sciencedaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from sciencedaily.com Daily Mail and Mail on Sunday newspapers.

United States , Jifeng Zhang , Eugene Chen , Michigan Medicine , Laboratory Animal Center , Xi An Jiaotong University Health Science Center , Cardiovascular Sciences , Peking University Health Science Center , Huetwell Professor , Cardiovascular Medicine , Michigan Medical ,

Tripeptide Treats Fatty Liver Disease in Non-Human Primates

Researchers say studies describe a highly translatable NASH model and highlight the need for clinical evaluation of DT-109. ....

United States , Jifeng Zhang , Eugene Chen , University Of Michigan , Michigan Medicine , Huetwell Professor , Cardiovascular Medicine , Michigan Medical , Cell Metabolism , Laboratory Animal Center , Xi An Jiaotong University Health Science Center , Cardiovascular Sciences , Peking University Health Science , Diapin Therapeutics ,

Drug Candidate for Fatty Liver Disease Shows Promise in Animal Models

A recently developed amino acid compound successfully treats nonalcoholic fatty liver disease in non-human primates, bringing scientists one step closer to the first human treatment for the condition. ....

United States , Jifeng Zhang , Eugene Chen , Technology Network , Michigan Medicine , Laboratory Animal Center , Xi An Jiaotong University Health Science Center , Cardiovascular Sciences , Peking University Health Science Center , Huetwell Professor , Cardiovascular Medicine , Michigan Medical ,

Potential drug DT-109 brings hope for human fatty liver treatment

Washington, Apr 11 (Prensa Latina) A recently developed amino acid compound successfully treats nonalcoholic fatty liver disease in non-human primates bringing scientists one step closer to the first human treatment for the condition that is rapidly increasing around the world, a study suggests. ....

United States , Jifeng Zhang , Eugene Chen , Michigan Medicine , Laboratory Animal Center , Xi An Jiaotong University Health Science Center , Cardiovascular Sciences , Peking University Health Science Center , Huetwell Professor , Cardiovascular Medicine , Michigan Medical ,